|
|
News Breaks
|
November 24, 2009
|
| 07:20 EDT |  | RDY |
| theflyonthewall.com: | Dr Reddy’s Vizag plant in India gets U.S. FDA clearance, Live Mint reports | | LiveMint.com is reporting that Dr Reddy’s Laboratories Ltd (RDY) has received FDA clearance for one plant in India and given a minor observation at the other. Dr Reddy’s Bachupally plant in Andhra Pradesh received one 483, or an observation from the investigator that there is some deviation from current Good Manufacturing Practices, or cGMPs. Meanwhile, its Vizag facility, which had previously been given 483s, was cleared by the team. The team of inspectors from the U.S. FDA is also expected to inspect Lupin’s Mandideep facility in Madhya Pradesh and Ranbaxy’s Tonsa plant in Punjab by the end of this year. Reference Link :theflyonthewall.com |
|
|
News For RDY From The Last 14 Days Check below for free stories on RDY the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 7, 2012
|
| 09:53 EDT |  | RDY |
| theflyonthewall.com: | Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse (pre-open) |
 Subscribe for More Information :theflyonthewall.com |
|
|
February 3, 2012
|
| 05:52 EDT |  | RDY |
| | 05:52 EDT | | RDY |
| theflyonthewall.com: | Dr. Reddy's Labs reports Q3 EPS 0.6 vs. 0.3 in Q3 of FY11 | | Reports Q3 revenue $522M, up 46% yoy. Consensus $1.89B [1 estimate] :theflyonthewall.com |
|
|
|
|
|
